Events & Conferences

Small Pharma to participate in the 34th Annual Roth Conference

Presentation to be webcast on Monday, March 14 at 3:30 – 3:55PM/PT

Small Pharma is pleased to announce its participation at the 34th Annual Roth Conference 2022.

A fireside chat will be hosted by a banking analyst from Roth in discussion with Small Pharma’s CEO, Peter Rands and Chief Medical and Scientific Officer, Dr. Carol Routledge. Small Pharma will also take part in a panel discussion, Psychedelics: “Immunotherapy” for the Mind. Both will be available by live webcast via the links below.

Details for the fireside chat and panel session are as follows:


Fireside Chat  

Presenters: Peter Rands, CEO and Dr Carol Routledge, Chief Medical and Science Officer 

When: Monday, March 14 from 3.30PM – 3.55PM / PT

Webcast Link Registration: Fireside Chat


Panel Discussion 

When: Tuesday, March 15 from 10AM / PT

Webcast Link Registration: Panel – Psychedelics: Immunotherapy for the Mind


Meeting Availability

To schedule a one-on-one meeting with the Small Pharma’s management team, please contact your Roth representative directly, or email smallpharmair@kcsa.com 

About Small Pharma

We’re a mental health drug development company that’s accelerating the development of fast acting antidepressant treatments using DMT based therapies. We’re dedicated to making a difference.

Get Small Pharma
Investor Updates

    Investor Deck

    Follow us: